Researcher
Ann Smeets
- Disciplines:Morphological sciences, Oncology, Orthopaedics, Surgery, Nursing
Affiliations
- Surgical Oncology (Division)
Member
From1 Jan 2012 → Today
Projects
1 - 10 of 10
- iSurvive-Mind Helpt het geheugen van (ex-)kankerpatiëntenFrom1 May 2023 → TodayFunding: Provinces
- The enigma of subjective lymphedema: Why do patients report lymphedema after breast cancer treatment without an objective measurable swelling? The role of sensory processing and subclinical lymphedema – LymphSens TrialFrom1 Jan 2023 → TodayFunding: FWO research project (including WEAVE projects)
- Impact of adiposity and lifestyle on breast cancer biology and treatment response.From7 Oct 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Identifying prognostic variables for persistent upper limb dysfunctions after breast cancer treatment: body functions, personal and environmental factors according to the International Classification of Functioning, Disease and Health (ICF)From25 Oct 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Identifying prognostic variables for persistent upper limb dysfunctions after breast cancer treatment: body functions, personal and environmental factors according to the International Classification of Functioning, Disease and Health (ICF)From1 Oct 2021 → TodayFunding: BOF - projects
- Connecting Single-cell Immune Profiling in Peripheral Blood with Intratumoral T Cell Expansion in Breast Cancer Upon Checkpoint ImmunotherapyFrom24 Aug 2021 → TodayFunding: FWO Strategic Basic Research Grant
- A mindfulness-based intervention as candidate to reduce cognitive impairment and recover brain changes after breast cancer treatment.From2 Jan 2019 → 1 Jan 2024Funding: FWO Strategic Basic Research Grant
- What causes cognitive decline after treatment for breast cancer? A multiparametric neuroimaging studyFrom4 Sep 2017 → 14 Sep 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- Role of combined chemo- and immunotherapy in early breast cancerFrom1 Oct 2016 → 30 Sep 2020Funding: Nonprofit institution or equivalents
- Effect of pembrolizumab on biomarkers related to intratumoral immunity, proliferation and apoptosis in early breast cancerFrom1 Oct 2016 → 15 Nov 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
41 - 50 of 151
- Neuroinflammation and Its Association with Cognition, Neuronal Markers and Peripheral Inflammation after Chemotherapy for Breast Cancer(2021)
Authors: Gwen Schroyen, Jeroen Blommaert, Charlotte Sleurs, Mathieu Vandenbulcke, Sigrid Hatse, An Goris, Michel Koole, Ann Smeets, Koen Van Laere, Stefan Sunaert, et al.
- Concordance between results of inexpensive statistical models and multigene signatures in patients with ER+/HER2-early breast cancer(2021)
Authors: Laurence Slembrouck, Isabelle Vanden Bempt, Hans Wildiers, Ann Smeets, Anne-Sophie Van Rompuy, Chantal Van Ongeval, Caroline Weltens, Kevin Punie, Els Van Nieuwenhuysen, Sileny Han, et al.
Pages: 1297 - 1309 - Quantitative Sensory Testing in Women after Surgery for Breast Cancer: A Systematic Review and Narrative Synthesis(2021)
Authors: Lore Dams, Elien Van der Gucht, Ann Smeets, Vincent Haenen, Tessa De Vrieze, An De Groef
Pages: 1 - 52 - Cause of death for patients with breast cancer: discordance between death certificates and medical files, and impact on survival estimates(2021)
Authors: Hava Izci, Hans Wildiers, Kevin Punie, Eva Oldenburger, Els Van Nieuwenhuysen, Ann Smeets, Ines Nevelsteen, Patrick Neven
- Blood Immunosenescence Signatures Reflecting Age, Frailty and Tumor Immune Infiltrate in Patients with Early Luminal Breast Cancer(2021)
Authors: Lieze Berben, Cindy Kenis, Ann Smeets, Hanne Vos, Patrick Neven, Beppe Floris, Hans Wildiers, Sigrid Hatse
- A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer(2021)
Authors: Ayse Bassez, Hanne Vos, Laurien Van Dyck, Beppe Floris, Ingrid Arijs, Christine Desmedt, Bram Boeckx, Marlies Vanden Bempt, Ines Nevelsteen, Kathleen Lambein, et al.
Pages: 820 - + - Immune-related adverse events after a single dose of pembrolizumab(2021)
Authors: Hanne Vos, Kathleen Lambein, Hans Wildiers, Kevin Punie, Ann Smeets
Pages: 92 - 94 - Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk(2021)
Authors: Sigrid Hatse, Diether Lambrechts, Ann Smeets, Caroline Weltens
Pages: 329 - 337 - Body mass index and tumor infiltrating lymphocytes in triple-negative breast cancer(2021)
Authors: Beppe Floris, François Richard, Hans Wildiers, Kevin Punie, Ann Smeets, Ignace Vergote, Patrick Neven, Christine Desmedt
Pages: 146 - 153 - Features of durable response and treatment efficacy for capecitabine monotherapy in advanced breast cancer: real-world evidence from a large single-centre cohort(2021)
Authors: Hans Wildiers, Kevin Punie, Benoit Beuselinck, Paul Clement, Sileny Han, Els Van Nieuwenhuysen, Ignace Vergote, Ann Smeets, Ines Nevelsteen, Beppe Floris, et al.
Pages: 1041 - 1048